Emyria Ltd(EMD.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

EMD.AU Emyria Ltd

Closed 04-18 16:12:00 AEST

0.06

+0.00

-5.08%

High0.06	Low0.06	Vol71.09K
Open0.06	D1 Closing0.06	Amplitude5.08%
Mkt Cap20.53M	Tradable Cap9.02M	Total Shares366.63M
T/O4.09K	T/O Rate0.04%	Tradable Shares161.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EMD.AU","market":"AU","secType":"STK","nameCN":"Emyria Ltd","latestPrice":0.056,"timestamp":1713420720000,"preClose":0.059,"halted":0,"volume":71088,"delay":0,"floatShares":161090210,"shares":366629396,"eps":-0.038006,"marketStatus":"Closed","marketStatusCode":5,"change":-0.003,"latestTime":"04-18 16:12:00 AEST","open":0.058,"high":0.059,"low":0.056,"amount":4089,"amplitude":0.050847,"askPrice":0.057,"askSize":53949,"bidPrice":0.056,"bidSize":48585,"shortable":3,"etf":0,"ttmEps":-0.038006,"exchange":"ASX","tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1713484800000},"adr":0,"adjPreClose":0.059,"openAndCloseTimeList":[[1713398400000,1713420000000]],"volumeRatio":0.324069,"nameEN":"Emyria Ltd","tradeCurrency":"AUD","lotSize":1},"requestUrl":"/m/hq/s/EMD.AU","defaultTab":"news","newsList":[{"id":"2426310078","title":"The fixed income opportunity with \"a lot more to give\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2426310078","media":"LiveWire","top":-1,"share":"https://ttm.financial/m/news/2426310078?lang=en_us&edition=fundamental","pubTime":"2024-04-10 11:00","pubTimestamp":1712718018,"startTime":"0","endTime":"0","summary":"Webster outlined the case for EM debt, highlighting the returns on offer for much less risk than used to be the case.Markets have moved significantly since then, amid changing interest rate expectations, so I reached out to Webster again to get an update on how he is viewing the opportunity in emerging markets, what impact those changing expectations are having, and how he and his team are positioning the portfolio right now.Grant Webster, Co-Head of Emerging Market Sovereign & FX at Ninety One. Since the end of 2023, emerging markets debt  has continued to perform. At the end of the year, EMD had outperformed Global and Developed market debt over 1-year, 3-years and 5-years. In 2023, EM Local Currency Debt returned 12%, Hard Currency Sovereign Debt returned 11% and Hard Currency Corporate Debt returned 9%.Furthermore, with much of the painful interest-rate hiking now behind them, most EM economies are in an enviable position relative to developed markets overall, with","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/the-fixed-income-opportunity-with-a-lot-more-to-give","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/the-fixed-income-opportunity-with-a-lot-more-to-give","is_publish_highlight":false,"gpt_icon":0},{"id":"2424832449","title":"Emyria partners with ‘Reach Wellness’ to support PTSD patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2424832449","media":"The Market Herald","top":-1,"share":"https://ttm.financial/m/news/2424832449?lang=en_us&edition=fundamental","pubTime":"2024-04-03 11:11","pubTimestamp":1712113860,"startTime":"0","endTime":"0","summary":"Emyria Limited  Share Price | Latest News – The Market Online, a trailblazer in mental health treatment innovation, has teamed up with charity group ‘Reach Wellness’ to spearhead a pivotal study to support post-traumatic stress disorder  sufferers.The research aims to assess the effectiveness of Emyria’s MDMA-assisted therapy  program, alongside Reach Wellness’ support initiatives, for those battling PTSD.The collaboration underscores Emyria’s commitment to pioneering solutions in mental health care. Since launching community-based MDMA-assisted therapy trials in October 2023, the company’s lead psychiatrist has obtained Authorised Prescriber status, allowing Emyria to offer MDMA-assisted therapy for PTSD under stringent regulatory oversight.Under the research study agreement, Reach Wellness will launch a fundraising campaign to cover treatment and follow-up expenses for an initial group of 50 screened first responders eligible for MDMA-AT. This initiative represents a significant inve","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://themarketonline.com.au/emyria-partners-with-reach-wellness-to-support-ptsd-patients-2024-04-03/","is_publish_highlight":false,"gpt_icon":0},{"id":"2424882446","title":"BRIEF-Emyria Enters Binding Research Study Agreement With Charity Reach Wellness","url":"https://stock-news.laohu8.com/highlight/detail?id=2424882446","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2424882446?lang=en_us&edition=fundamental","pubTime":"2024-04-03 09:17","pubTimestamp":1712107072,"startTime":"0","endTime":"0","summary":"April 3 (Reuters) - Emyria Ltd   :   * ENTERED INTO A BINDING RESEARCH STUDY AGREEMENT WITH CHARITY REACH WELLNESS   * AGREEMENT TO MANAGE OBSERVATIONAL STUDY TO EVALUATE EFFECTIVENESS OF EMYRIA'S MDMA-ASSISTED THERAPY PROGRAM Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424400770","title":"Emyria Insider Purchases Yet To Pay Off Regardless Of Recent Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2424400770","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2424400770?lang=en_us&edition=fundamental","pubTime":"2024-04-02 04:00","pubTimestamp":1712001648,"startTime":"0","endTime":"0","summary":"Insiders who bought AU$600.8k worth of Emyria Limited ( ASX:EMD ) stock in the last year have seen some of their losses...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-emd/emyria-shares/news/emyria-insider-purchases-yet-to-pay-off-regardless-of-recent","is_publish_highlight":false,"gpt_icon":0},{"id":"2421291750","title":"EDF: Emerging Markets Deliver The Goods","url":"https://stock-news.laohu8.com/highlight/detail?id=2421291750","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2421291750?lang=en_us&edition=fundamental","pubTime":"2024-03-22 00:37","pubTimestamp":1711039029,"startTime":"0","endTime":"0","summary":"Emerging countries are those with developing economies that are likely to grow in the near future.Some well-known emerging countries include Brazil, Russia, China, and India, but there are many others","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/906600424/image_906600424.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/906600424/image_906600424.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4679662-edf-emerging-markets-deliver-the-goods","is_publish_highlight":false,"gpt_icon":0},{"id":"2402424291","title":"Stocks of the Hour: Gladiator Resources, Kali Metals, Emyria","url":"https://stock-news.laohu8.com/highlight/detail?id=2402424291","media":"Informed Investor","top":-1,"share":"https://ttm.financial/m/news/2402424291?lang=en_us&edition=fundamental","pubTime":"2024-01-10 08:43","pubTimestamp":1704847383,"startTime":"0","endTime":"0","summary":"A snapshot of the stocks on the move, featuring Gladiator Resources, Kali Metals and Emyria.","market":null,"thumbnail":"https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/ec374edb435aa1009e4be6ec00c5756d2548d197.jpg","type":0,"news_type":0,"thumbnails":["https://informed-investor.s3.ap-southeast-2.amazonaws.com/images/News/ec374edb435aa1009e4be6ec00c5756d2548d197.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.sharecafe.com.au/2024/01/10/stocks-of-the-hour-gladiator-resources-kali-metals-emyria/","is_publish_highlight":false,"gpt_icon":0},{"id":"2381487896","title":"This ASX All Ords biotech share is on a 16% tear today","url":"https://stock-news.laohu8.com/highlight/detail?id=2381487896","media":"MotleyFool","top":-1,"share":"https://ttm.financial/m/news/2381487896?lang=en_us&edition=fundamental","pubTime":"2023-11-07 08:44","pubTimestamp":1699317875,"startTime":"0","endTime":"0","summary":"The Race Oncology Ltd  share price is catching the eye on Tuesday.In morning trade, the ASX All Ords biotech share is up 16% to $1.05.Investors have been buying the oncology focused biotechnology company's shares today following the release of a positive announcement.This relates to interim clinical results from an ongoing investigator-initiated Phase 2 trial of bisantrene in combination with fludarabine and clofarabine  in relapsed or refractory Acute Myeloid Leukaemia  patients.Furthermore, the ASX All Ords biotech share revealed that five of the six treatment-responsive patients were able to be bridged to a stem cell transplant  within one to three months of treatment.This clinical trial of bisantrene in combination with intensive chemotherapy produced very encouraging results in younger AML patients with advanced relapsed, refractory and resistant acute myeloid leukaemia . Many of these patients achieved a complete or a partial remission, enabling a significant proportion to go on ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.fool.com.au/2023/11/07/this-asx-all-ords-biotech-share-is-on-a-16-tear-today/","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.emeraldclinics.com.au","stockEarnings":[{"period":"1week","weight":-0.0484},{"period":"1month","weight":-0.0484},{"period":"3month","weight":-0.0328},{"period":"6month","weight":-0.0484},{"period":"1year","weight":-0.6312},{"period":"ytd","weight":0.1346}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.0643},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.085},{"period":"ytd","weight":0.059}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Emerald Clinics Limited operates a network of patient-centered medical clinics that offer cannabinoid-based treatment services. It operates four medical centers in Australia. The company was incorporated in 2018 and is based in North Perth, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.110034},{"month":2,"riseRate":0.4,"avgChangeRate":0.016245},{"month":3,"riseRate":0.4,"avgChangeRate":0.028045},{"month":4,"riseRate":0,"avgChangeRate":-0.127531},{"month":5,"riseRate":0,"avgChangeRate":-0.158453},{"month":6,"riseRate":0.25,"avgChangeRate":-0.007283},{"month":7,"riseRate":0.75,"avgChangeRate":0.259447},{"month":8,"riseRate":0,"avgChangeRate":-0.073686},{"month":9,"riseRate":0.25,"avgChangeRate":-0.022214},{"month":10,"riseRate":0.5,"avgChangeRate":0.184309},{"month":11,"riseRate":0.25,"avgChangeRate":-0.074696},{"month":12,"riseRate":0.25,"avgChangeRate":0.054186}],"exchange":"ASX","name":"Emyria Ltd","nameEN":"Emyria Ltd"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Emyria Ltd(EMD.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Emyria Ltd(EMD.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Emyria Ltd,EMD.AU,Emyria Ltd股票,Emyria Ltd股票老虎,Emyria Ltd股票老虎国际,Emyria Ltd行情,Emyria Ltd股票行情,Emyria Ltd股价,Emyria Ltd股市,Emyria Ltd股票价格,Emyria Ltd股票交易,Emyria Ltd股票购买,Emyria Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Emyria Ltd(EMD.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Emyria Ltd(EMD.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction